Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris

Marine-derived actinobacteria isolated from sponge Cliona varians and soft coral Eunicea fusca were screened for antibacterial activity against acne-related bacteria, specifically Staphylococcus epidermidis ATCC 14990, methicillin-resistant Staphylococcus aureus ATCC BAA44, and Cutibacterium acnes A...

Full description

Saved in:
Bibliographic Details
Main Authors: María Clara De La Hoz-Romo, Luis Díaz, Javier Gómez-León, Marynes Quintero, Luisa Villamil
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2024.1501951/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841558695043923968
author María Clara De La Hoz-Romo
María Clara De La Hoz-Romo
Luis Díaz
Luis Díaz
Javier Gómez-León
Marynes Quintero
Luisa Villamil
author_facet María Clara De La Hoz-Romo
María Clara De La Hoz-Romo
Luis Díaz
Luis Díaz
Javier Gómez-León
Marynes Quintero
Luisa Villamil
author_sort María Clara De La Hoz-Romo
collection DOAJ
description Marine-derived actinobacteria isolated from sponge Cliona varians and soft coral Eunicea fusca were screened for antibacterial activity against acne-related bacteria, specifically Staphylococcus epidermidis ATCC 14990, methicillin-resistant Staphylococcus aureus ATCC BAA44, and Cutibacterium acnes ATCC 6919. Cytotoxicity assays were performed on human dermal fibroblast (HDFa) and keratinocyte (HaCaT) cell lines to assess the safety profile of the extracts. Chemical characterization was conducted using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC–MS/MS). Among the extracts, six derived from Kocuria sp., Rhodococcus sp., Nocardia sp., Micrococcus sp., and Streptomyces sp. demonstrated significant antibacterial activity. Notably, extract Z9.216 from Kocuria sp. exhibited the highest efficacy, inhibiting S. epidermidis by 68%, S. aureus by 93%, and C. acnes by 98.7% at a concentration of 0.003 mg/mL, which was comparable to the standard antibiotics erythromycin and vancomycin, while maintaining over 90% cell viability in both HDFa and HaCaT cell lines. Untargeted metabolomic analysis suggested that antibacterial activity might be associated with compounds from the chemical families of alkaloids, terpenoids, and fatty acids, among others. These findings highlight the therapeutic potential of marine actinobacteria in underexplored environments as a promising strategy for treating acne vulgaris, a chronic inflammatory skin condition.
format Article
id doaj-art-6559e2664280461b812fe78ed1542a5a
institution Kabale University
issn 1664-302X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-6559e2664280461b812fe78ed1542a5a2025-01-06T06:59:17ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-01-011510.3389/fmicb.2024.15019511501951Marine actinobacteria metabolites: unlocking new treatments for acne vulgarisMaría Clara De La Hoz-Romo0María Clara De La Hoz-Romo1Luis Díaz2Luis Díaz3Javier Gómez-León4Marynes Quintero5Luisa Villamil6Doctoral Program of Biosciences, School of Engineering, Universidad de La Sabana, Chía, Cundinamarca, ColombiaBioprospecting Research Group, School of Engineering, Universidad de La Sabana, Chía, ColombiaDoctoral Program of Biosciences, School of Engineering, Universidad de La Sabana, Chía, Cundinamarca, ColombiaBioprospecting Research Group, School of Engineering, Universidad de La Sabana, Chía, ColombiaMarine Bioprospecting Line, Marine and Coastal Research Institute “José Benito Vives de Andréis” INVEMAR, Santa Marta, ColombiaMarine Bioprospecting Line, Marine and Coastal Research Institute “José Benito Vives de Andréis” INVEMAR, Santa Marta, ColombiaDoctoral Program of Biosciences, School of Engineering, Universidad de La Sabana, Chía, Cundinamarca, ColombiaMarine-derived actinobacteria isolated from sponge Cliona varians and soft coral Eunicea fusca were screened for antibacterial activity against acne-related bacteria, specifically Staphylococcus epidermidis ATCC 14990, methicillin-resistant Staphylococcus aureus ATCC BAA44, and Cutibacterium acnes ATCC 6919. Cytotoxicity assays were performed on human dermal fibroblast (HDFa) and keratinocyte (HaCaT) cell lines to assess the safety profile of the extracts. Chemical characterization was conducted using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC–MS/MS). Among the extracts, six derived from Kocuria sp., Rhodococcus sp., Nocardia sp., Micrococcus sp., and Streptomyces sp. demonstrated significant antibacterial activity. Notably, extract Z9.216 from Kocuria sp. exhibited the highest efficacy, inhibiting S. epidermidis by 68%, S. aureus by 93%, and C. acnes by 98.7% at a concentration of 0.003 mg/mL, which was comparable to the standard antibiotics erythromycin and vancomycin, while maintaining over 90% cell viability in both HDFa and HaCaT cell lines. Untargeted metabolomic analysis suggested that antibacterial activity might be associated with compounds from the chemical families of alkaloids, terpenoids, and fatty acids, among others. These findings highlight the therapeutic potential of marine actinobacteria in underexplored environments as a promising strategy for treating acne vulgaris, a chronic inflammatory skin condition.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1501951/fullmarine actinobacteriaacne vulgarisantibacterial activitysecondary metabolitesCutibacterium acnes
spellingShingle María Clara De La Hoz-Romo
María Clara De La Hoz-Romo
Luis Díaz
Luis Díaz
Javier Gómez-León
Marynes Quintero
Luisa Villamil
Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris
Frontiers in Microbiology
marine actinobacteria
acne vulgaris
antibacterial activity
secondary metabolites
Cutibacterium acnes
title Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris
title_full Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris
title_fullStr Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris
title_full_unstemmed Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris
title_short Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris
title_sort marine actinobacteria metabolites unlocking new treatments for acne vulgaris
topic marine actinobacteria
acne vulgaris
antibacterial activity
secondary metabolites
Cutibacterium acnes
url https://www.frontiersin.org/articles/10.3389/fmicb.2024.1501951/full
work_keys_str_mv AT mariaclaradelahozromo marineactinobacteriametabolitesunlockingnewtreatmentsforacnevulgaris
AT mariaclaradelahozromo marineactinobacteriametabolitesunlockingnewtreatmentsforacnevulgaris
AT luisdiaz marineactinobacteriametabolitesunlockingnewtreatmentsforacnevulgaris
AT luisdiaz marineactinobacteriametabolitesunlockingnewtreatmentsforacnevulgaris
AT javiergomezleon marineactinobacteriametabolitesunlockingnewtreatmentsforacnevulgaris
AT marynesquintero marineactinobacteriametabolitesunlockingnewtreatmentsforacnevulgaris
AT luisavillamil marineactinobacteriametabolitesunlockingnewtreatmentsforacnevulgaris